we conclude that , due to differences in expression of tag-72 in benign versus malignant cells , the monoclonal antibody against tag-72 ( b72.3 ) may be suitable for radio-immunodetection or radio-immunotherapy of pancreatic cancer .
C0334227
malignant cells
C0235974
of pancreatic cancer